Aerolizer® = Cyclohaler

Patient feedback of dosen taken (visual/acoustic)

Lactose carrier (taste feedback)

N/A Dose counter

Dose counter measuring inhalations actually taken

Accurate & consistent dose delivery

FPF air flow rate independence

> 6yrs Achievable IFR (asthmatic child, severe asthma COPD)

Device resistance

Minimum FR controlled to achieve adequate lung deposition?

N/A Overdose-secure

(1) Dose metering: blister pack (maximum)

Reservoir (maximum)

N/A  Advance warning of last dose

Protection from ambient humidity

N/A Device lock.out

N/A Reloadable

1 Max. number of doses



How to use Aerolizer®/Cyclohaler

With a low intrinsic resistance the Aerolizer®/Cyclohaler® releases already 70% of the metered dose at an inspiratory flow of 28 l/min. However under these conditions the is fairly large with an average value of 7.9 µm. Increasing the flow to 40 l/min the average particle size decreases to 4.4 µm but further increase of flow results in only slight reduction of particle size.

The Aerolizer®/Cyclohaler® is a single dose system using gelatine capsules for drug formulation. Inhalation procedure has to be repeated several times before the capsule is completely emptied possibly leading to inaccurate dosing during inhalation. Since after each usage a new capsule needs to be inserted treatment with the Aerolizer is not very convenient for the patient.

Drugs approved for use with the Aerolizer®/Cyclohaler® include budesonide (Miflonide®), formoterol (Foradil®), beclomethasone (Becotide®, Miflasone®) and salbutamol (Sultanol®).

This section contains a list of things you should do (DOs) and things you shouldn’t do (DON’Ts) when using the Aerolizer/Cyclohaler. This list only covers items known from practice to be the most important and most likely to be forgotten or performed incorrectly by patients; this information is in addition to the prescribing and other information provided with the Aerolizer/Cyclohaler.